WAM
STJ

Wolverine Asset Management’s St Jude Medical STJ Stock Holding History

Wolverine Asset Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-327
Closed -$1K – 1426
2016
Q1 		$1K Sell
327
-73
-18% -$3.98K ﹤0.01% 1187
2015
Q4 		$69K Buy
+400
New +$25.2K ﹤0.01% 1074
2015
Q1 		– Sell
-11
Closed -$1K – 2401
2014
Q4 		$1K Sell
11
-60
-85% -$3.86K ﹤0.01% 2083
2014
Q3 		$35K Hold
71
– – ﹤0.01% 1635
2014
Q2 		$84K Buy
71
+4
+6% +$259 ﹤0.01% 1217
2014
Q1 		$61K Buy
67
+17
+34% +$1.11K ﹤0.01% 1286
2013
Q4 		$50K Sell
50
-10
-17% -$579 ﹤0.01% 1765
2013
Q3 		$37K Sell
60
-15
-20% -$773 ﹤0.01% 1844
2013
Q2 		$17K Buy
+75
New +$3.25K ﹤0.01% 2078

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wolverine Asset Management's STJ Position: Q1 2017 in Review

Wolverine Asset Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 60,786 shares — an estimated $4.87M sold.

Wolverine Asset Management first reported a position in STJ in Q2 2013 and held it in 7 quarters. The position peaked at $8.68M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Wolverine Asset Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Wolverine Asset Management sold 60,786 St Jude Medical shares in Q1 2017, an estimated $4.87M.
  • Wolverine Asset Management first reported a position in St Jude Medical in Q2 2013 and held it in 7 quarters.
  • Wolverine Asset Management's St Jude Medical position peaked at $8.68M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Wolverine Asset Management's 13F filing for Q1 2017, filed 15 May 2017.